Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • 6 hours ago

Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know

Coltharp executed the sale of 18,869 shares at a weighted average price of $125.38 per share on August 10. The transaction reduced the executive's direct equity position by 27%, while his total beneficial ownership decreased by 7%.

The Motley Fool • Aug 16, 2026

Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know

The transaction involved 173,148 shares sold at a weighted average price of $125.47, totaling approximately $21.7 million. This disposition represents 39% of the CEO's direct common stock holdings in the company.

The Motley Fool • Aug 16, 2026

What Three Encompass Health Insiders Selling Signals After a Rate Increase

The transaction realized approximately $1.1 million at a weighted average price of $125.95 per share. The executive reduced his direct common stock holdings by 11% through this open-market sale.

The Motley Fool • Aug 16, 2026

Encompass Health announces launch of private offering of 5.875% senior notes due 2034

BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5.875% senior notes maturing in 2034 (the "Additional Notes"), subject to market and other conditions.

PRNewsWire • Aug 10, 2026

Encompass Health prices private offering of additional 5.875% senior notes due 2034

BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034 (the "Additional Notes") at a price of 98.75% of the principal amount thereof.

PRNewsWire • Aug 10, 2026

Encompass Health Q2 Earnings Call Highlights

Encompass Health NYSE: EHC reported second-quarter 2026 results marked by revenue, earnings and discharge growth, prompting the inpatient rehabilitation provider to raise its full-year outlook.

MarketBeat • Aug 8, 2026

Encompass Health Beats Q2 Earnings Estimates, Raises '26 View

EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.

Zacks Investment Research • Aug 7, 2026

Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Aug 7, 2026

Encompass Health Corporation (EHC) Q2 2026 Earnings Call Transcript

Encompass Health Corporation (EHC) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 6, 2026